Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Gastroenterology|April 1, 1984
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel diseaseC Fiocchi, M L Hilfiker, K R Youngman, et al.
Cancer Research|February 15, 1990
Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor levelN F Chikkala, I Lewis, J Ulchaker, et al.
Lymphokine Research|January 1, 1985
Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable eventsJ H Finke, B Yen-Lieberman, J W Scott, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1979
Inactivation of complement by Loxosceles reclusa spider venomH M Gebel, J H Finke, K D Elgert, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2001
Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytesV M Kolenko, R G Uzzo, N Dulin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumorC S Tannenbaum, R Tubbs, D Armstrong, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|January 1, 1992
Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell lineJ H Finke, P Rayman, M Edinger, et al.
The American Journal of Pathology|April 1, 1994
Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2K Sonouchi, T A Hamilton, C S Tannenbaum, et al.
Urology|February 1, 1989
In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinomaM M Ziegelbaum, J H Finke, R Tubbs, et al.
Anticancer Research|May 1, 1992
Therapeutic efficacy of interleukin-2 activated killer cells against adriamycin resistant mouse B16-BL6 melanomaS C Gautam, N F Chikkala, I Lewis, et al.
Pageof 5